相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: An Open-Label Observational Study
Itay Lotan et al.
CLINICAL NEUROPHARMACOLOGY (2014)
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
M. H. N. Chagas et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Javier Fernandez-Ruiz et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Effects of acute systemic administration of cannabidiol on sleep-wake cycle in rats
Marcos Hortes N. Chagas et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients
Mateus M. Bergamaschi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Exploração farmacológica do sistema endocanabinoide: novas perspectivas para o tratamento de transtornos de ansiedade e depressão?
Viviane M. Saito et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2011)
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors
T. V. Zanelati et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cannabidiol: A Promising Drug for Neurodegenerative Disorders ?
Teresa Iuvone et al.
CNS NEUROSCIENCE & THERAPEUTICS (2009)
Cannabis and anxiety: a critical review of the evidence
Jose Alexandre Crippa et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2009)
Cannabidiol for the treatment of psychosis in Parkinson's disease
A. W. Zuardi et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2009)
Therapeutic effects of Δ9-THC and modafinil in a marmoset Parkinson model
Sanneke A. M. van Vliet et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2008)
Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action
Antonio Waldo Zuardi
REVISTA BRASILEIRA DE PSIQUIATRIA (2008)
Dorsolateral prefrontal cortex N-acetylaspartate/total creatine (NAA/tCr) loss in male recreational cannabis users
Derik Hermann et al.
BIOLOGICAL PSYCHIATRY (2007)
Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease:: Importance of antioxidant and cannabinoid receptor-independent properties
Moises Garcia-Arencibia et al.
BRAIN RESEARCH (2007)
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro:: Relevance to Parkinson's disease
I Lastres-Becker et al.
NEUROBIOLOGY OF DISEASE (2005)
Survey on cannabis use in Parkinson's disease:: Subjective improvement of motor symptoms
K Venderová et al.
MOVEMENT DISORDERS (2004)
Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: Results from a multicenter clinical trial
A Siderowf et al.
MOVEMENT DISORDERS (2002)
分享论文
